Sensible Medicine

APRIL 25, 2024

The US FDA is under tremendous political pressure to approve drugs, and indeed they tout the number of approved drugs as a measure of the quality of their work. Unfortunately, you can approve bad drugs. Selenexor is a toxic poison that does not increase survival. Belantumab causes eye damage and had to be pulled from the US market Idelalisib, copanlisib, duvelisib— the entire P13k inhibitor class —may have resulted in increased deaths.

Poisoning 135

Poisoning Outcomes 135

St. Emlyn

APRIL 25, 2024

St.Emlyn's - Emergency Medicine #FOAMed Part 2 of our podcast on top papers from 2023/24 with @EMManchester and @docb #FOAMed @stemlyns The post Top papers podcast 2023/24. Part 2. St Emlyn’s appeared first on St.Emlyn's.

94

94

Science Based Medicine

APRIL 25, 2024

Two papers look at the effects of cold water immersion after exercise, with mixed results. The post Cold Water Immersion Not Always Beneficial first appeared on Science-Based Medicine.

85

85

American Medical Compliance

APRIL 25, 2024

The following MRI Level 2 Training is designed to educate healthcare professionals with Level 2 clearance on proper safety guidelines when using MRIs. This advanced training not only broadens the foundational knowledge obtained in Level 1 but also equips practitioners with specialized skills to handle complex imaging scenarios and interpret subtle nuances in MRI scans.

Radiology 52

Radiology Radiology Operations Research 52

PDC Healthcare

APRIL 25, 2024

Children in hospitals often experience anxiety, fear, and discomfort during procedures and even routine checkups. This can lead to distress, resistance, and even safety risks. Traditional methods to manage these challenges can be invasive or have limited effectiveness. Time constraints can also limit the type of methods used to manage these challenges.

Pediatrics 52

Pediatrics Hospitals Patient Safety 52

PulmCCM

APRIL 25, 2024

Patients with certain spontaneous intracerebral hemorrhages treated with minimally invasive surgery had improved functional outcomes compared to those treated with usual care, the ENRICH randomized trial showed. Treatment options for spontaneous interest cerebral hemorrhage have remained severely limited, with little improvement in outcomes over decades.

Outcomes 52

Outcomes 52